ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,206, issued on Oct. 21, was assigned to The Scripps Research Institute (La Jolla, Calif.).
"Nanoparticle vaccines with novel structural components" was invented by Linling He (San Diego) and Jiang Zhu (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel nanoparticle presented vaccine compositions that are stabilized with a locking domain. Various immunogens can be employed in the preparation of the vaccine compositions, including viral immunogens such as HIV-1 and Ebola viral immunogens, and non-viral immunogens such as immunogens derived from bacteria, parasites and mammalian species. The invention also pro...